Compiled By: Malami Haruna Dogondaji
OCTOBER 8, 2026 – ABUJA, NIGERIA
Beijing has officially nominated senior National Health Commission official Song Li to succeed Tedros Adhanom Ghebreyesus as Director-General of the World Health Organization, positioning China at the center of a high-stakes leadership contest.
Who is Song Li?
Song Li is a distinguished senior health official at China’s National Health Commission with approximately two decades of experience specializing in maternal and child health policy and international cooperation. Her career includes frontline response coordination for major public health crises, including SARS, avian influenza, and COVID-19.
In 2020, she served as editor-in-chief of a publication focused on COVID-19 prevention and control, which helped shape national guidelines for safeguarding women and children during the pandemic. If elected, Song would make history as the first person from mainland China to head the UN health agency. Hong Kong-born Margaret Chan previously served as the WHO’s director-general from 2007 to 2017.
A Competitive Global Race to Succeed Tedros
Song enters a crowded international field vying to replace incumbent Director-General Tedros Adhanom Ghebreyesus, whose second and final five-year term concludes on August 15, 2027. Other publicly announced contenders include:
- Hanan Mohammed Al-Kuwari of Qatar
- Hanan Balkhy of Saudi Arabia
- Hans Kluge of Belgium
- María Neira of Spain
- Budi Gunadi Sadikin of Indonesia
- Gevorg Tamamyan of Botswana
While the initial nomination deadline closed on September 24, the WHO permits governments to delay public announcements until regional nomination processes conclude. The definitive candidate list is scheduled for publication following regional committee meetings.
Expanding Influence Amid US Withdrawal
China’s nomination arrives as Beijing actively seeks a larger footprint within major international organizations, coinciding with a reduction of US engagement in the United Nations system. Earlier this year, the United States completed its formal withdrawal from the WHO under the Trump administration, stepping back from its role as a principal financial contributor following heavy criticism of the agency’s pandemic response and allegations of pro-Beijing bias—claims the WHO has consistently rejected.
Analysts note that China’s bid could expand its sway over global health policy during a period of financial uncertainty for the agency, while also driving broader representation for Chinese officials across international structures.
Scrutiny Over Independence and Transparency
Although Song’s robust technical background strengthens Beijing’s pitch, her candidacy is certain to reignite debates over transparency during the early stages of the COVID-19 pandemic and the balance of political influence within the agency.
The path ahead requires navigating a rigorous selection process: the 34-member WHO Executive Board will review candidates at its 160th session in early 2027, narrowing the field to a maximum of three candidates for the World Health Assembly to vote on during its May 2027 meeting.
Fast Facts: WHO Leadership Election
- Nominee: Dr. Song Li (National Health Commission, China)
- Current Incumbent: Tedros Adhanom Ghebreyesus (Term ends August 15, 2027)
- Executive Board Review: Early 2027 (160th Session)
- Final Appointment: Eightieth World Health Assembly (May 2027)
The Social Call-to-Action
How do you view China’s bid to lead the World Health Organization amid shifting global alliances? Join the discussion on NTA’s social media channels @NTANetwork
